• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    2/9/24 4:31:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email
    SC 13G/A 1 d653237dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G/A

    (Rule 13d-102)

    INFORMATION TO BE INCLUDED IN STATEMENTS

    FILED PURSUANT TO RULES 13d-1(b), (c), AND (d)

    AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2

    (Amendment No. 17)

     

     

    Align Technology, Inc.

    (Name of Issuer)

    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

    016255101

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP NO. 016255101    13G/A    Page 2 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Grant Gund, as trustee for the Gordon Gund – Grant Gund #2 Trust, the Grant Gund 1999 Trust, the Gordon Gund - Grant Gund GST Article III Trust, the Gordon Gund - Grant Gund GST Article III-A Trust, the Llura Blair Gund Gift Trust, the Grant Owen Gund Gift Trust, the Kelsey Laidlaw Gund Gift Trust and the 2011 Grant Gund Descendants’ Trust and as sole manager of OLK Investments LLC and OLK Brookfield LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     884,603

       6  

     SHARED VOTING POWER

     

     171,000

       7  

     SOLE DISPOSITIVE POWER

     

     884,603

       8  

     SHARED DISPOSITIVE POWER

     

     171,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     1,055,603

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.4%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 3 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    G. Zachary Gund, as trustee for the Gordon Gund – G. Zachary Gund #2 Trust, the Z Coppermine Trust, the Gordon Gund—G. Zachary Gund GST Article III Trust, the Gordon Gund - G. Zachary Gund GST Article III-A Trust, the G. Zachary Gund Descendants’ Trust, the Georgia Swift Gund Gift Trust and the Grant Gund 2017 Remainder Trust and as sole manager of GCG Investments LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     1,284,279

       6  

     SHARED VOTING POWER

     

     3,000

       7  

     SOLE DISPOSITIVE POWER

     

     1,284,279

       8  

     SHARED DISPOSITIVE POWER

     

     3,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     1,287,279

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.7%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 4 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Gordon Gund, as the sole manager of Gund CLAT Investments, LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     850,647

       6  

     SHARED VOTING POWER

     

     0

       7  

     SOLE DISPOSITIVE POWER

     

     850,647

       8  

     SHARED DISPOSITIVE POWER

     

     0

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     850,647

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.1%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 5 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Alison I. Glover, as trustee for the Llura Blair Gund Gift Trust, the Grant Owen Gund Gift Trust, the Kelsey Laidlaw Gund Gift Trust and the Georgia Swift Gund Gift Trust

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     0

       6  

     SHARED VOTING POWER

     

     174,000

       7  

     SOLE DISPOSITIVE POWER

     

     0

       8  

     SHARED DISPOSITIVE POWER

     

     174,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     174,000

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.2%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 6 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Dionis Trust

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Ohio

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     -0-

       6  

     SHARED VOTING POWER

     

     187,700

       7  

     SOLE DISPOSITIVE POWER

     

     -0-

       8  

     SHARED DISPOSITIVE POWER

     

     187,700

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     187,700

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.2%

    12  

     TYPE OF REPORTING PERSON

     

     OO


    CUSIP NO. 016255101    13G/A    Page 7 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Marital Trust for Gordon Gund

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Ohio

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     -0-

       6  

     SHARED VOTING POWER

     

     574,550

       7  

     SOLE DISPOSITIVE POWER

     

     -0-

       8  

     SHARED DISPOSITIVE POWER

     

     574,550

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     574,550

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.8%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 8 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Gordon & Llura Gund Foundation

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     New Jersey

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     -0-

       6  

     SHARED VOTING POWER

     

     424,465

       7  

     SOLE DISPOSITIVE POWER

     

     -0-

       8  

     SHARED DISPOSITIVE POWER

     

     424,465

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     424,465

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.6%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 9 of 14 Pages

     

    This Amendment No. 17 (“Amendment No. 17”) amends and supplements the Schedule 13G as originally filed by Llura L. Gund, Grant Gund, G. Zachary Gund, Gordon Gund, Richard T. Watson, Rebecca H. Dent, George Gund III and Gail Barrows on September 25, 2002, the Amendment No. 1 filed on November 25, 2002, the Amendment No. 2 filed on February 17, 2004, the Amendment No. 3 filed on February 14, 2005, the Amendment No. 4 filed on February 7, 2006, the Amendment No. 5 filed on February 14, 2007, the Amendment No. 6 filed on February 13, 2009, the Amendment No. 7 filed on February 13, 2013, the Amendment No. 8 filed on February 14, 2014, the Amendment No. 9 filed on February 9, 2016, the Amendment No. 10 filed on February 9, 2017, the Amendment No. 11 filed on February 8, 2018, the Amendment No. 12 filed on February 11, 2019, the Amendment No. 13 filed on February 7, 2020, the Amendment No. 14 filed on February 11, 2021, the Amendment No. 15 filed on February 7, 2022 and the Amendment No. 16 filed on February 1, 2023 (as so amended, the “Schedule 13G”). Capitalized terms used but not defined in this Amendment No. 17 have the respective meaning ascribed to them in the Schedule 13G.

    Item 2 (a) of the Schedule 13G, “Identity and Background,” is hereby amended by deleting the last paragraph thereof and inserting the following:

    The Reporting Persons, in the aggregate, beneficially own 4,380,244 shares of Common Stock or 5.7% of the outstanding Common Stock of the Issuer based on 76,589,114 shares outstanding as of October 27, 2023 as reported in the Quarterly Report on Form 10-Q of the Issuer for the period ended September 30, 2023. Neither the fact of this filing nor anything contained herein shall be deemed to be an admission by any of the Reporting Persons that a group exists within the meaning of the Exchange Act.

    Item 4 of the Schedule 13G, “Ownership” is hereby amended and restated in its entirety as follows:

    Pursuant to the Exchange Act and regulations thereunder, the Reporting Persons may be deemed as a group to have acquired beneficial ownership of 4,380,244 shares of Common Stock, which represents 5.7% of the outstanding Common Stock of the Issuer.

    Grant Gund may be deemed to have beneficial ownership in the aggregate of 1,055,603 shares of Common Stock, which constitutes 1.4% of the outstanding Common Stock of the Issuer. Of these shares, Grant Gund has sole power to vote and sole power to dispose of an aggregate of 884,603 shares of Common Stock by virtue of his position as the sole manager or trustee or investment trustee of certain entities listed below and may be deemed to have shared power to vote and shared power to dispose of 171,000 shares of Common Stock by virtue of his position as co-trustee of certain trusts as listed below:

     

    Gordon Gund – Grant Gund #2 Trust (Mr. Grant Gund serves as investment trustee)

         270,379  

    Grant Gund 1999 Trust (Mr. Grant Gund serves as sole trustee)

         90,320  

    OLK Investments LLC (Mr. Grant Gund serves as sole manager)

         80,516  

    OLK Brookfield LLC (Mr. Grant Gund serves as sole manager)

         8,532  

    Gordon Gund - Grant Gund GST Article III Trust (Mr. Grant Gund serves as investment trustee)

         280,349  

    Gordon Gund - Grant Gund GST Article III-A Trust (Mr. Grant Gund serves as investment trustee)

         107,000  

    2011 Grant Gund Descendants’ Trust (Mr. Grant Gund serves as investment trustee)

         47,507  


    CUSIP NO. 016255101    13G/A    Page 10 of 14 Pages

     

    Llura Blair Gund Gift Trust (Mr. Grant Gund serves as co-trustee with Alison I. Glover)

         50,165  

    Grant Owen Gund Gift Trust (Mr. Grant Gund serves as co-trustee with Alison I. Glover)

         50,165  

    Kelsey Laidlaw Gund Gift Trust (Mr. Grant Gund serves as co-trustee with Alison I. Glover)

         70,670  

    G. Zachary Gund may be deemed to have beneficial ownership in the aggregate of 1,287,279 shares of Common Stock, which constitutes 1.7% of the outstanding Common Stock of the Issuer. Of these shares, G. Zachary Gund has sole power to vote and sole power to dispose of 1,284,279 shares of Common Stock by virtue of his position as the sole manager or trustee or investment trustee of certain entities listed below and may be deemed to have shared power to vote and shared power to dispose of 3,000 shares by virtue of his position as co-trustee for certain trusts as indicated below:

     

    Gordon Gund – G. Zachary Gund #2 Trust (Mr. G. Zachary Gund serves as investment trustee)

         328,887  

    Z Coppermine Trust (Mr. G. Zachary Gund serves as sole trustee)

         121,069  

    GCG Investments LLC (Mr. G. Zachary Gund serves as sole manager)

         14,875  

    Gordon Gund – G. Zachary Gund GST Article III Trust (Mr. G. Zachary Gund serves as investment trustee)

         322,998  

    Grant Gund 2017 Remainder Trust (Mr. G. Zachary Gund serves as trustee)

         11,450  

    Gordon Gund – G. Zachary Gund GST Article III-A Trust (Mr. G. Zachary Gund serves as investment trustee)

         107,000  

    G. Zachary Gund Descendants’ Trust (Mr. G. Zachary Gund serves as investment trustee)

         378,000  

    Georgia Swift Gund Gift Trust (Mr. G. Zachary Gund serves as co-trustee with Alison I. Glover)

         3,000  

    Gordon Gund may be deemed to have beneficial ownership of 850,647 shares of Common Stock, which constitutes 1.1% of the outstanding Common Stock of the Issuer. Gordon Gund, as sole manager of Gund CLAT Investments, LLC has sole power to vote and sole power to dispose of 850,647 shares of Common Stock.

    Alison I. Glover may be deemed to have beneficial ownership in the aggregate of 174,000 shares of Common Stock, which constitutes 0.2% of the outstanding Common Stock of the Issuer. Of these shares, Alison I. Glover may be deemed to have shared power to vote and shared power to dispose of an aggregate of 174,000 shares of Common Stock by virtue of her position as co-trustee for certain trusts as indicated below:

     

    Llura Blair Gund Gift Trust (Ms. Glover serves as co-trustee with Grant Gund)

         50,165  

    Grant Owen Gund Gift Trust (Ms. Glover serves as co-trustee with Grant Gund)

         50,165  

    Kelsey Laidlaw Gund Gift Trust (Ms. Glover serves as co-trustee with Grant Gund)

         70,670  

    Georgia Swift Gund Gift Trust (Ms. Glover serves as co-trustee with G. Zachary Gund)

         3,000  

    The Dionis Trust may be deemed to have beneficial ownership of 187,700 shares of Common Stock, which constitutes 0.2% of the outstanding Common Stock of the Issuer. The Dionis Trust has shared power to vote and shared power to dispose of 187,700 shares of Common Stock.


    CUSIP NO. 016255101    13G/A    Page 11 of 14 Pages

     

    The Marital Trust for Gordon Gund may be deemed to have beneficial ownership of 574,550 shares of Common Stock, which constitutes 0.8% of the outstanding Common Stock of the Issuer. The Marital Trust for Gordon Grund has shared power to vote and shared power to dispose of 574,550 shares of Common Stock.

    The Gordon & Llura Gund Foundation may be deemed to have beneficial ownership of 424,465 shares of Common Stock, which constitutes 0.6% of the outstanding Common Stock of the Issuer. The Gordon & Llura Gund Foundation has shared power to vote and shared power to dispose of 424,465 shares of Common Stock.

    Item 10. Certifications. (See Instructions)

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    CUSIP NO. 016255101    13G/A    Page 12 of 14 Pages

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 9, 2024

     

    By:   /s/ Catherine Bird
      Name: Catherine Bird
      For herself and as Attorney-in-Fact for the
      Reporting Persons

     

    *

    The Power of Attorney authorizing Catherine Bird to act on behalf of the Reporting Persons is attached hereto as Exhibit A.

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

    Get the next $ALGN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    2/14/2025$255.00Overweight
    Wells Fargo
    1/6/2025$235.00 → $280.00Market Perform → Outperform
    Leerink Partners
    12/4/2024$295.00Outperform
    Mizuho
    10/10/2024Hold
    Needham
    2/26/2024$310.00Market Perform
    Leerink Partners
    12/11/2023$197.00Neutral → Sell
    Goldman
    10/27/2023$200.00Buy → Neutral
    UBS
    More analyst ratings

    $ALGN
    Leadership Updates

    Live Leadership Updates

    See more
    • Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

      Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

      3/25/25 4:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

      5/22/24 5:00:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

      Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition

      2/8/23 4:55:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Financials

    Live finance-specific insights

    See more
    • Align Technology Announces First Quarter 2025 Financial Results

      Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

      4/30/25 4:15:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology to Announce First Quarter 2025 Results on April 30, 2025

      Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi

      4/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Announces Fourth Quarter and Fiscal 2024 Financial Results

      Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively Q4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year Q4 Systems and Services revenues up 5.2% sequentially, and up 14.9% year-over-year 2024 total revenues of $4.0 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $768.9 million 2024 revenues were unfavorably impacted by foreign exchange of approximately $38.5 million compared to 2023(1) 2024 operating margin of 15.2%, non-GAAP operating margin of 21.8%, and diluted net income per share of $5.62, non-GA

      2/5/25 4:05:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Align Technology Announces New $1 Billion Stock Repurchase Program

      Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has authorized a new stock repurchase program. Under the new program, Align may purchase up to $1.0 billion of its common stock over the next three years. The company's prior $1 billion authorization approved in January 2023 was completed on May 1, 2025 (with settlement on May 2, 2025). "We are pleased to announce that our Board of Directors has authorized a new $1 billion sto

      5/6/25 9:00:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology to Speak at Upcoming Financial Conferences

      Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately one month. Conference: Bank of America 2025 Healthcare Conference Date: Tuesday, May 13, 2025

      5/1/25 8:30:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Announces First Quarter 2025 Financial Results

      Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

      4/30/25 4:15:00 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Align Tech downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00

      4/25/25 8:29:20 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Wells Fargo initiated coverage on Align Tech with a new price target

      Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00

      2/14/25 7:02:00 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Tech upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Align Tech from Market Perform to Outperform and set a new price target of $280.00 from $235.00 previously

      1/6/25 7:28:53 AM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      8/19/24 6:35:02 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Hogan Joseph M bought $999,845 worth of shares (5,194 units at $192.50), increasing direct ownership by 3% to 208,664 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      11/9/23 8:35:10 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Hogan Joseph M bought $999,972 worth of shares (5,319 units at $188.00), increasing direct ownership by 3% to 203,470 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      11/1/23 5:18:50 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    SEC Filings

    See more
    • SEC Form 10-Q filed by Align Technology Inc.

      10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      5/8/25 5:14:03 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      5/6/25 9:00:29 AM ET
      $ALGN
      Industrial Specialties
      Health Care
    • Align Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

      4/30/25 4:06:37 PM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/13/24 4:59:02 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/9/24 4:31:42 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

      SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

      2/9/23 11:07:31 AM ET
      $ALGN
      Industrial Specialties
      Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann converted options into 3,341 shares and covered exercise/tax liability with 965 shares, increasing direct ownership by 51% to 7,068 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:47:20 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • EVP GLOBAL HR Hockridge Stuart A converted options into 2,587 shares and covered exercise/tax liability with 696 shares, increasing direct ownership by 20% to 11,558 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:46:27 PM ET
      $ALGN
      Industrial Specialties
      Health Care
    • EVP & CHIEF FINANCIAL OFFICER Morici John converted options into 4,539 shares and covered exercise/tax liability with 1,509 shares, increasing direct ownership by 23% to 16,023 units (SEC Form 4)

      4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

      2/24/25 6:45:47 PM ET
      $ALGN
      Industrial Specialties
      Health Care